Paxlovid
The Latest
-
Paxlovid COVID-19 Pill Effective For Elderly But May Not Benefit Young Adults
When administered soon after infection, Paxlovid reduced hospitalizations among those 65 and older by almost 75%, according to the study. 
When administered soon after infection, Paxlovid reduced hospitalizations among those 65 and older by almost 75%, according to the study. -
U.S. FDA Permits Pharmacists To Prescribe COVID-19 Pill By Pfizer
Now, U.S. pharmacists can directly recommend the most popular COVID-19 medication to patients. Now, U.S. pharmacists can directly recommend the most popular COVID-19 medication to patients. -
Pfizer COVID-19 Pills Show Promise, But Experts Warn Risk Of Harmful Reaction With Other Medications
Still, experts touted the new COVID drug as a game-changer. Still, experts touted the new COVID drug as a game-changer. -
U.S. To Buy $5 Billion Worth Of Pfizer's Paxlovid COVID-19 Treatment
The White House is reportedly planning to purchase 10 million doses of Pfizer's Paxlovid COVID-19 treatment, at an estimated cost of $5 billion. The White House is reportedly planning to purchase 10 million doses of Pfizer's Paxlovid COVID-19 treatment, at an estimated cost of $5 billion.
